Seeing Is Believing
Currently out of the existing stock ratings of Michael Okunewitch, 1 are a HOLD (8.33%), 11 are a BUY (91.67%).
Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 7.14% that have a potential upside of 28.15% achieved within 10 days.
Michael Okunewitch’s has documented 23 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCWB, HCW Biologics at 29-May-2025.
Analyst best performing recommendations are on ANEB (ANEBULO PHARMACEUTICALS).
The best stock recommendation documented was for ANEB (ANEBULO PHARMACEUTICALS) at 5/15/2025. The price target of $3 was fulfilled within 69 days with a profit of $1.99 (197.03%) receiving and performance score of 28.56.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Jul-2021
$14
$10.37 (285.67%)
$11
4 months 10 days ago
(22-Oct-2025)
0/5 (0%)
$8.36 (148.23%)
Buy Since 18-Oct-2021
$15
$11.37 (313.22%)
$15
5 months 9 days ago
(23-Sep-2025)
0/7 (0%)
$9.39 (167.38%)
Buy Since 13-Jul-2021
1 years 8 months 11 days ago
(21-Jun-2024)
0/1 (0%)
$26.23 (139.74%)
Buy Since 13-Jul-2021
$9
$5.37 (147.93%)
2 years 9 months 20 days ago
(12-May-2023)
0/3 (0%)
$7.1 (373.68%)
Buy Since 12-Nov-2021
2 years 11 months 5 days ago
(27-Mar-2023)
0/1 (0%)
$17.08 (114.48%)
What Year was the first public recommendation made by Michael Okunewitch?